logo

XBIO

Xenetic Biosciences·NASDAQ
--
--(--)
--
--(--)
3.96 / 10
Netural

With a fund flow rating of 7.91/10, the stock shows robust fund flow characteristics. Supportive momentum from overall, block, Small, Medium, Large, and Extra-large trends is partially offset by concerning no significant trends patterns, pointing to positive capital flow trajectory. Research analyst consensus shows divided analyst consensus, demonstrating neutral perspective. Current ratings: Neutral(100.0%) across 1 coverage providers, supported by 0.00 historical weighted rating.

FundamentalSentiment(3.96)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

0%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-04-09
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of XBIO?
  • XBIO holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.96/10 (Netural).